Citation only
via OpenAlex
753-P: Senolytics Improve Diabetes Measures in Type 2 Diabetic Nonhuman Primates: A Pilot Study
Alistaire D. Ruggiero, Masha R. Block, MATTHEW DAVIS, Ravichandra Vemuri, Miranda E. Orr, Kylie Kavanagh
Diabetes · 2021 · ▲ 2 citations
Abstract
Senescent cells accumulate in adipose tissue (AT) with obesity, causing local inflammation and dysfunction. Senescent cells in aging nonhuman primate (NHP) AT correlated with metabolic disease measures in our previous work. In this pilot study, we evaluated the senolytic combination dasatinib plus quercetin (D+Q) on AT senescent cell burden and systemic metabolic health in obese NHPs with naturally occurring type II diabetes (T2D; n=3). Selected NHPs remained stable on insulin therapy for six months prior to the study. NHPs were given a single oral dose of D (5mg/kg) plus Q (50mg/kg). Blood samples were collected 1 week prior to, and 4 and 8 weeks post-treatment. Abdominal subcutaneous (SQ) AT biopsies were taken before and 1 week after dosing. Senescence(definition)-associated beta galactosidase (SA-β-gal) staining showed 24% reductions in AT senescent cell burden. Two animals had large reductions in the senescence biomarker plasminogen activator inhibitor 1 (mean=55%). Dramatic improvements in A1c, fasting glucose (FBG), cholesterol (TPC) and triglycerides (TG) were reported in all subjects, in the absence of weight loss. A1c decreased by 1-2% and FBG by > 100mg/dL (Cohen’s d = 3.81 and 2.78). Post-prandial glucoses were unchanged. Similarly, TPC and TG reduced by >25mg/dL and > 130mg/dL (Cohen’s d = 0.73 and 1.55). Improvements in fasting and overall glycemic measures, and lipid profiles suggest effects on hepatic metabolism. Reductions in creatinine were also seen post-treatment without changes in urea, which may indicate reduced muscle catabolism. Our results show a single D+Q treatment has potent and long-lasting effects for improved metabolism in T2D. Disclosure A. D. Ruggiero: None. M. Block: None. M. Davis: None. R. Vemuri: None. M. E. Orr: None. K. Kavanagh: None. Funding National Heart, Lung, and Blood Institute (R01HL142930)
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2337/db21-753-p
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Ruggiero, A.D., Block, M.R., DAVIS, M., Vemuri, R., Orr, M.E., & Kavanagh, K. (2021). 753-P: Senolytics Improve Diabetes Measures in Type 2 Diabetic Nonhuman Primates: A Pilot Study. <em>Diabetes</em>. https://doi.org/10.2337/db21-753-p
Vancouver
Ruggiero AD, Block MR, DAVIS M, Vemuri R, Orr ME, Kavanagh K. 753-P: Senolytics Improve Diabetes Measures in Type 2 Diabetic Nonhuman Primates: A Pilot Study. Diabetes. 2021. doi:10.2337/db21-753-p.
BibTeX
@article{alistaire2021PSenol,
title = {753-P: Senolytics Improve Diabetes Measures in Type 2 Diabetic Nonhuman Primates: A Pilot Study},
author = {Alistaire D. Ruggiero and Masha R. Block and MATTHEW DAVIS and Ravichandra Vemuri and Miranda E. Orr and Kylie Kavanagh},
journal = {Diabetes},
year = {2021},
doi = {10.2337/db21-753-p},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Diabetes 2010
Open access · OA
Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
Journal of Translational Medicine 2019
Open access · CC-BY
Metabolic signature of obesity-associated insulin resistance and type 2 diabetes
Barnes Retina Institute 2007
Open access · US-GOV
An Open-Label, Single-Site, Comparative, Pilot Study of the Treatment Effects of Combination Therapy of Lucentis (Ranibizumab) Plus Reduced Fluence Photodynamic Therapy With Visudyne in Patients With Exudative Age-Related Macular Degeneration (AMD)
The Aging Male 2003
Open access · OA
Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency
The American Journal of Medicine 2010
Open access · OA
Serum Uric Acid Levels and the Risk of Type 2 Diabetes: A Prospective Study
Bay Area Retina Associates 2006
Open access · US-GOV